Clinical Trials Logo
  1. Home
  2. Covid19
  3. NCT04661462
  4. Details
NCT04661462 Clinical Trial

Health After Covid-19 in Tyrol

COVID-19 Clinical Trial

Official title:
Health After COVID-19 in the European Region Tyrol - South Tyrol

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04661462
Other study ID # 20200928-2379
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 30, 2020
Est. completion date December 31, 2021

Study information
Verified date September 2020
Source Medical University Innsbruck
Contact Judith Löffler-Ragg, MD
Phone ++43-512-504-81413
Email judith.loeffler@i-med.ac.at
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of the regional online questionnaire is to better understand the pattern of acute infection and the time of recovery of various symptoms.

Description:

The ongoing COVID-19 pandemic considerably increases the demand for healthcare and raises concerns on longterm disease outcome. Accordingly, to increase the knowledge on recovery from symptoms of acute infection and longterm health effects, a regional COVID-19 online survey on the health-status after infection will be performed. This cross-sectional anonymous online survey is initiated and conducted by an interdisciplinary study team of the Medical University of Innsbruck, Austria. For each participant, demographic characteristics (e.g. age, gender, district affiliation, profession), medical history (presence of comorbidities, medication), diagnosis of COVID-19, symptoms and their duration, treatments and special conditions will be collected. The aim of the survey is to better understand the pattern of acute infection and the time of recovery of various symptoms. The anonymous online survey is open to individuals after COVID-19 infection (proven by SARS-Cov-2 positive PCR or antibody test) over the age of 16 and living in Tyrol (Western-Austria). The survey takes around 30 minutes to complete.

Recruitment information / eligibility
Status Recruiting
Enrollment 1000
Est. completion date December 31, 2021
Est. primary completion date September 30, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria: - status post COVID-19 infection, defined by a positive SARS-Cov-2 PCR or antibody test - age = 16years - resident in Tyrol (Austria) Exclusion Criteria:

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• online survey
We invite volunteers after COVID-19 to participate in an online survey.

Locations
Country Name City State
Austria Medizinische Universität Innsbruck Innsbruck Tyrol

Sponsors (2)
Lead Sponsor Collaborator
Medical University Innsbruck Claudiana Landesfachhochschule

Country where clinical trial is conducted

Austria, 

Outcome
Type Measure Description Time frame Safety issue
Primary Population based data on spectrum and recovery from COVID-19 symptoms Percentage of patients manifesting ongoing symptoms after 2 weeks of infection. two weeks after infection
Primary Population based data on spectrum and recovery from COVID-19 symptoms Spectrum of symptoms at onset and at end of disease. up to 24 weeks
Primary Predictors of recovery. Identification of symptoms or comorbidities associated with Long-Covid-19. up to 24 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Active, not recruiting NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure